These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8532940)
21. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
22. [The problem of sudden death in heart failure]. Delise P; Sciarra L Ital Heart J; 2005 May; 6 Suppl 1():24S-33S. PubMed ID: 15945297 [TBL] [Abstract][Full Text] [Related]
23. Sudden death prophylaxis in heart failure. Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319 [TBL] [Abstract][Full Text] [Related]
24. Secondary prevention of sudden cardiac death. Curnis A; Mascioli G; Bontempi L; Bordonali T; Dei Cas L Ital Heart J; 2005 Mar; 6(3):216-20. PubMed ID: 15875512 [TBL] [Abstract][Full Text] [Related]
25. Secondary prevention of sudden cardiac death in coronary artery spasm: is implantable cardioverter defibrillator always efficient? Letsas KP; Filippatos GS; Efremidis M; Sideris A; Kardaras F Int J Cardiol; 2007 Apr; 117(1):141-3. PubMed ID: 17046086 [TBL] [Abstract][Full Text] [Related]
26. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. de Bie MK; van Dam B; Gaasbeek A; van Buren M; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW Eur Heart J; 2009 Jul; 30(13):1559-64. PubMed ID: 19465437 [TBL] [Abstract][Full Text] [Related]
27. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Khairy P; Harris L; Landzberg MJ; Fernandes SM; Barlow A; Mercier LA; Viswanathan S; Chetaille P; Gordon E; Dore A; Cecchin F Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):250-7. PubMed ID: 19808416 [TBL] [Abstract][Full Text] [Related]
28. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death. Thakor NV; Natarajan A Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992 [TBL] [Abstract][Full Text] [Related]
29. Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death. Berul CI Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S67-70. PubMed ID: 19602167 [TBL] [Abstract][Full Text] [Related]
30. Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation. Botto GL; Proclemer A; Luzi M; Ruffa F; Gorgoglione MG; Ferrari G Ital Heart J; 2005 Mar; 6(3):210-5. PubMed ID: 15875511 [TBL] [Abstract][Full Text] [Related]
31. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605 [TBL] [Abstract][Full Text] [Related]
32. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310 [TBL] [Abstract][Full Text] [Related]
33. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Slade AK; Camm AJ Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163 [TBL] [Abstract][Full Text] [Related]
39. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy. Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264 [TBL] [Abstract][Full Text] [Related]
40. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator. Prystowsky EN Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]